We live in exciting times for adherence, and the pharma industry is playing a critical role, according to Mark Degatano, a pharmaceutical industry analytics expert who is on the advisory board of AllazoHealth. Degatano’s expertise…
Read more
Payers, pharmacies and pharmaceutical companies are starting to join providers in recognizing that social determinants of health (SDOH) have a major impact on patient adherence and clinical outcomes. Healthcare organizations now face the challenge of…
Read more
What do payers consider as they grapple with the medication access and adherence needs of at-risk patients during the Covid-19 pandemic? Experts at McMann Managed Markets and Syneos Health surveyed their proprietary payer advisory boards…
Read more
AllazoHealth, a company that uses artificial intelligence (AI) to help enterprise healthcare companies improve medication adherence and quality outcomes, has released a new study demonstrating the impact of AI on patient adherence indicators. The poster…
Read more